Systemic sclerosis & Raynaud's
Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review
Authors' conclusion
The outcome domains and the associated outcomes used to assess the impact of SSc-RP in research studies are broad and have varied across studies.
Study context
- Population
- Clinical studies of adult participants with SSc-associated raynaud's phenomenon (RP) (randomized control trials (RCTs), quasi-randomised, case-control, cohort, case series, cross-sectional), in English; Embase, MEDLINE, Cochrane CENTRAL58 studies (24 RCTs)
- Outcome
- Outcome domains studied and outcome measures used in clinical studies of SSc-RP
Methodological detailsOMERACT
- OMERACT
Main finding
As reported in the abstract
Commonest outcome domains captured (number of studies)
Severity of attacks
35
Frequency of attacks
28
Duration of attacks
19
Original publication
Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review. Semin Arthritis Rheum. Published 27 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →